Naproxen EP Impurity I

Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form
Papanaboina Venkatarao,*,1,2 Morrisetty Nagendra Kumar,1 and Maram Ravi Kumar
Sci Pharm. 2012 Oct-Dec; 80(4): 965–976
                             
Determination of Potential Impurities of Naproxen Sodium in Soft Gelatin Capsules Dosage by Using Ultra Performance Liquid Chromatography
R. Srikanth Reddy, R. Murali Krishna, N.A. Vekaria, Rao V. Sumathi & Bhaskara P.V. Mantena
TACL 6 (1) 2016 pp 55 – 69
 
High-Performance Liquid Chromatographic Method Development and Validation for the Simultaneous Quantitation of Naproxen Sodium and Pseudoephedrine Hydrochloride Impurities
Anthony Ekpe, Julin H. Tong, Laura Rodriguez
Journal of Chromatographic Science, Volume 39, Issue 3, March 2001, Pages 81–86
 
Development and Validation of Related Substances Method by HPLC for Analysis of Naproxen in Naproxen Tablet Formulations
Pakhuri Mehta1*, Chandra Shekhar Sharma1 , Deepak Nikam2 , M. S. Ranawat
International Journal of Pharmaceutical Sciences and Drug Research 2012; 4(1): 63-69

Naproxen EP Impurity I is chemically (6-Methoxynaphthalen-2-yl)acetic acid (as per EP). Naproxen EP Impurity I is supplied with detailed characterization data compliant with regulatory guideline. Naproxen EP Impurity I can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Naproxen.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.